中文
WASHINGTON--()--The Biotechnology Industry Organization (BIO) will host a special China Day program dedicated to exploring questions about the changing landscape for innovation, healthcare reform, global regulatory trends and discuss the right ways to partner at the 2012 BIO International Convention in Boston, Mass.
The event will feature speakers with decades of experience conducting business in the Chinese life science sector. Panels will cover topics such as Healthcare Innovation in China, Developments in the IP Landscape in China, Global Trends in Biologics Regulations, China’s Changing Market and Cross-Border Partnering in Biotechnology.
| WHO: | Li Chen, President & CEO, Hua Medicine | |
| George Baeder, Life Sciences Practice Leader, Monitor Group Shanghai | ||
| Helen Chen, Head of China Life Sciences, L.E.K. Consulting | ||
| Geoffrey Eich, Executive Director, Biosimilars Strategic Planning & Ops, Amgen | ||
| Samir Khalil, Executive Director, Public Policy, Asia Pacific & China, Merck | ||
| Richard Kingham, Partner, Covington & Burling LLP | ||
| Sandra Dennis, Deputy General Counsel, BIO | ||
| Ying Luo, Chairman of the Board, Beijing Continent Pharmaceutical Co., LTD | ||
| John F. McDonald, Vice President, Co-Head BD/M&A, Biogen Idec | ||
| Xu Ming, Vice President, CCMHPIE | ||
| Alexander Natz, Secretary General, EUCOPE | ||
| Yinxiang Wang, CEO & CSO, Beta Pharamaceuticals Inc. | ||
| Xiaobin Wu, General Manager, Pfizer China | ||
| Zegong Zhang, Deputy Director-General, Beijing Pharma and Biotech Center | ||
| WHAT: | The event will feature substantive panel discussions, a Keynote lunch, featuring several presentations by Chinese bio parks and select members of the Chinese delegation will be invited to tour BIO member company Biogen Idec’s Boston facility. | |
| WHERE: | BIO International Convention, Boston Convention & Exhibition Center, Room 258A & 259A | |
| WHEN: | Monday, June 18, 9:00 am – 6:00 pm | |
| WHY: | As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological development in its 12th Five-year Plan. | |
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, a multiblog platform and monthly newsletter that aims to create an online biotech community where the the industry can connect to discuss the latest news. Subscribe to BIOtechNOW.
For more information:
Visit http://www.bio.org
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech